Stay updated on MCS110 Combo in TNBC Clinical Trial

Sign up to get notified when there's something new on the MCS110 Combo in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MCS110 Combo in TNBC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy study of MCS110 combined with carboplatin and gemcitabine in advanced Triple Negative Breast Cancer (TNBC) patients.
    Difference
    0.1%
    Check dated 2024-06-06T14:37:09.000Z thumbnail image
  7. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying that adult women with advanced TNBC and certain histological or cytological evidence are eligible. Previously, this section had no information provided.
    Difference
    23%
    Check dated 2024-05-22T21:37:59.000Z thumbnail image
  8. Check
    42 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:48:49.000Z thumbnail image

Stay in the know with updates to MCS110 Combo in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MCS110 Combo in TNBC Clinical Trial page.